Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. AAPL
4. CHYM
5. USO
6. IRT
7. QCOM
8. ASO
9. LAES
10. QQQ

Go back to Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress

Lantern Pharma (LTRN) Reports Q2 Loss of $0.31

July 30, 2020 7:43 AM EDT

Lantern Pharma (NASDAQ: LTRN) reported Q2 EPS of ($0.31), versus ($0.32) reported last year.

"Lantern Pharma achieved important scientific and operational milestones during the quarter that have us well positioned for growth as we focus on being the leader in A.I.-enabled oncology drug development," said Panna Sharma, CEO and... More